We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

News · May 24, 2021

Meds Used for Hospitalized COVID-19 Patients Shifted Over 2020

Dexamethasone and remdesivir use grew substantially, while azithromycin and hydroxychloroquine both declined from early peaks

HealthDay

 

Further Reading